LifeMD (LFMD) Proxy Filing summary
Event summary combining transcript, slides, and related documents.
Proxy Filing summary
1 Dec, 2025Executive summary
The 2025 Annual Meeting will be held virtually on June 13, 2025, with voting on director elections and auditor ratification.
Proxy materials are available online, and shareholders are encouraged to vote electronically or by mail.
Seven directors are nominated for re-election, and CBIZ CPAs, P.C. is proposed as the independent auditor for 2025.
Voting matters and shareholder proposals
Shareholders will vote to elect seven directors and to ratify the selection of CBIZ CPAs, P.C. as the independent auditor for 2025.
Only shareholders of record as of April 23, 2025, are entitled to vote.
Board recommends voting for all director nominees and for auditor ratification.
Shareholder proposals for the 2026 meeting must be submitted by December 29, 2025.
Board of directors and corporate governance
Board consists of seven members, with a mix of independent and non-independent directors.
Committees include Audit, Compensation, and Nominating and Corporate Governance, all with independent members.
Board diversity is considered in nominations, focusing on experience, background, and skills.
Chairman and CEO roles are combined; independent directors can meet separately as needed.
All directors attended at least 75% of meetings in 2024.
Latest events from LifeMD
- Record revenue growth, expanding margins, and strong cash position drive 2026 outlook.LFMD
Q4 20259 Mar 2026 - Telehealth revenue rose 67% year-over-year, driving profitability and strong margin expansion.LFMD
Q2 20242 Feb 2026 - Q3 revenue up 38% to $53.4M, telehealth up 65%, gross margin 91%, and strong cash flow.LFMD
Q3 20242 Feb 2026 - Record revenue and EBITDA growth in 2024 set the stage for robust 2025 expansion.LFMD
Q4 202426 Jan 2026 - Up to $150M in securities, including $53.3M at-the-market stock, to fund growth and operations.LFMD
Registration Filing16 Dec 2025 - Resale of 1.28M shares highlights Medifast partnership and strong telehealth growth.LFMD
Registration Filing16 Dec 2025 - Telehealth firm launches $150M shelf registration, including $53.3M at-the-market equity offering.LFMD
Registration Filing16 Dec 2025 - Definitive proxy materials filed to solicit shareholder votes for upcoming LifeMD, Inc. meeting.LFMD
Proxy Filing1 Dec 2025 - First-ever GAAP profit and 49% revenue growth drive raised 2025 outlook and telehealth expansion.LFMD
Q1 202524 Nov 2025